The Lebanese Company for the Development and Reconstruction of Beirut Central District S.A.L. (BDB:SOLB)

Market Cap	1,209.53T
Revenue (ttm)	104.82B
Net Income (ttm)	-7.79B
Shares Out	n/a
EPS (ttm)	-48.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,388
Average Volume	4,807
Open	n/a
Previous Close	83.95
Day's Range	n/a
52-Week Range	72.55 - 129.50
Beta	n/a
RSI	47.16
Earnings Date	n/a

About Theseus Pharmaceuticals

The Lebanese Company for the Development and Reconstruction of Beirut Central District S.A.L., together with its subsidiaries, owns, develops, operates, and manages real estate properties in Lebanon. It develops real estate projects, such as residential projects; offices; hotels, resorts, and other hospitality projects; retail spaces, such as department stores, specialty stores, and entertainment complexes; and public, cultural, and social facilities and infrastructure, as well as develops land. The company also offers master and urban planning...

• Industry: Real Estate
• Founded: 1994
• Country: Lebanon
• Stock Exchange: Beirut Stock Exchange
• Ticker Symbol: SOLB

Financial Performance

In 2022, BDB:SOLB's revenue was $69.46 million, a decrease of -39.52% compared to the previous year's $114.85 million. Losses were -$5.17 million, 20.6% more than in 2021.